3billion, Inc. (KOSDAQ:394800)

South Korea · Delayed Price · Currency is KRW

6,470.00

+160.00 (2.54%)

At close: Aug 12, 2026

2.37% (1Y)

Market Cap	200.80B +0.2%
Revenue (ttm)	11.71B +102.8%
Net Income	-5.41B
EPS	-171.00
Shares Out	31.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128,581
Open	6,450.00
Previous Close	6,310.00
Day's Range	6,110.00 - 6,660.00
52-Week Range	4,260.00 - 20,100.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About 3billion

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2016

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 394800

Full Company Profile

Financial Performance

In 2025, 3billion's revenue was 11.71 billion, an increase of 102.85% compared to the previous year's 5.77 billion. Losses were -5.41 billion, -17.66% less than in 2024.

Financial Statements